mRNA vaccines — a new era in vaccinology

Pardi, Norbert, Hogan, Michael J., Porter, Frederick W., Weissman, Drew·2018·Nature Reviews Drug Discovery
DOI 10.1038/nrd.2017.243

Cites (218)

Items 201–217 of 217

  1. mRNA Cancer Vaccines—Messages that Prevail
    Christian R. Grunwitz, Lena M. Kranz · 2017 · Current topics in microbiology and immunology
  2. The combination of 4-1BBL and CD40L strongly enhances the capacity of dendritic cells to stimulate HIV-specific T cell responses
    Brenda De Keersmaecker, Carlo Heirman, Jurgen Corthals, Christophe Empsen, Leo A. van Grunsven, Sabine Danielle Allard, Joeri Jan Pen, Patrick Lacor, Kris Thielemans, Joeri L. Aerts · 2011 · Journal of Leukocyte Biology
  3. mRNA-based vaccines synergize with radiation therapy to eradicate established tumors
    Mariola Fotin‐Mleczek, Kai Zanzinger, Regina Heidenreich, Christina Lorenz, Aleksandra Kowalczyk, Karl‐Josef Kallen, Stephan M. Huber · 2014 · Radiation Oncology
  4. The 'anti-hype' vaccine
    Laura DeFrancesco · 2017 · Nature Biotechnology
  5. Introduction of functional chimeric E/L-selectin by RNA electroporation to target dendritic cells from blood to lymph nodes
    Jan Dörrie, Niels Schaft, Ina Müller, Verena Wellner, Tanja Schunder, Jens Hänig, Gertie Janneke Oostingh, Michael Peter Schön, Caroline Robert, Eckhart Kämpgen et al. · 2007 · Cancer Immunology Immunotherapy
  6. Whither vaccines?
    Charlene M.C. Rodrigues, Marta Valente Pinto, Manish Sadarangani, Stanley Alan Plotkin · 2017 · Journal of Infection
  7. The European Regulatory Environment of RNA-Based Vaccines
    Thomas Hinz, Kajo Kallen, Cedrik Michael Britten, Bruno Flamion, Ulrich Granzer, Axel Hoos, Christoph Huber, Samir N. Khleif, Sebastian Kreiter, Hans‐Georg Rammensee et al. · 2016 · Methods in molecular biology
  8. Childhood Vaccination
    David S. Younger, Adam P.J. Younger, Sally J. Guttmacher · 2016 · Neurologic Clinics
  9. Electroporation of RNA stimulates immunity to an encoded reporter gene in mice
    Atkins · 2009 · Molecular Medicine Reports
  10. PCSK9 inhibitors: monoclonal antibodies for the treatment of hypercholesterolemia
    David M. Paton · 2016 · Drugs of today
  11. Messenger RNA vaccination in NSCLC: Findings from a phase I/IIa clinical trial.
    M. Sebastian, Lotta von Boehmer, Alfred Zippelius, F. Mayer, Martin Reck, Djorde Atanackovic, Melissa Thomas, Folker Schneller, Jan Stoehlmacher, Eray Goekkurt et al. · 2011 · Journal of Clinical Oncology
  12. FLT3 Ligand as a Molecular Adjuvant for Naked RNA Vaccines
    Sebastian Kreiter, Mustafa Diken, Abderraouf Selmi, Jutta Petschenka, Özlem Türeci, Uğur Şahin · 2016 · Methods in molecular biology
  13. Dendritic cell vaccination in malignant pleural mesothelioma: A phase I/II study.
    Zwi Nisan Berneman, Paul R. Germonpré, Manon Thirza Huizing, Ann Van de Velde, Griet Nijs, Barbara Stein, Viggo F. Van Tendeloo, Eva Lion, Evelien Smits, Sébastien Anguille · 2014 · Journal of Clinical Oncology
  14. Immunogenicity and reactogenicity of two diphtheria-tetanus-whole cell pertussis vaccines in Iranian pre-school children, a randomized controlled trial
    Saeed Zarei, Mahmood Jeddi‐Tehrani, Mohammad Mehdi Akhondi, Hojjat Zeraati, Amir Ali Ferydonfar, Jalaledin Nasernia, Banafsheh Tavangar, Fazel Shokri · 2013 · Human Vaccines & Immunotherapeutics
  15. Biopharmaceuticals: Reference Products and Biosimilars to Treat Inflammatory Diseases
    Ann Gils, Antonio Bertolotto, Denis Mulleman, Théodora Bejan‐Angoulvant, Paul J. Declerck · 2017 · Therapeutic Drug Monitoring
  16. On message
    Kelly Servick · 2017 · Science
  17. Untitled work
    I Hoerr · 2000 · 10.1002/1521-4141(200001)30:1